{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:39:52Z","timestamp":1781739592253,"version":"3.54.5"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Both cerebral amyloid angiopathy (CAA) and hypertensive arteriopathy (HA) are related to cognitive impairment and dementia. This study aimed to clarify CAA- and HA-related small vessel disease (SVD) imaging marker associations with cognitive dysfunction and Alzheimer disease (AD) subtypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A sample of 137 subjects with clinically diagnosed late-onset AD identified from the dementia registry of a single center from January 2017 to October 2021 were enrolled. Semi-quantitative imaging changes (visual rating scale grading) suggestive of SVD were analyzed singularly and compositely, and their correlations with cognitive domains and AD subtypes were examined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients with typical and limbic-predominant AD subtypes had worse cognitive performance and higher dementia severity than minimal-atrophy subtype patients. Deep white matter hyperintensity (WMH) presence correlated inversely with short-term memory (STM) performance. The three composite SVD scores correlated with different cognitive domains and had distinct associations with AD subtypes. After adjusting for relevant demographic factors, multivariate logistic regression (using minimal-atrophy subtype as the reference condition) revealed the following: associations of the typical subtype with periventricular WMH [odds ratio (OR) 2.62; 95% confidence interval (CI), 1.23\u20135.57, <jats:italic>p<\/jats:italic>\u2009=\u20090.012], global SVD score (OR 1.67; 95%CI, 1.11\u20132.52, <jats:italic>p<\/jats:italic>\u2009=\u20090.009), and HA-SVD score (OR 1.93; 95%CI, 1.10\u20133.52, <jats:italic>p<\/jats:italic>\u2009=\u20090.034); associations of limbic-predominant subtype with HA-SVD score (OR 2.57; 95%CI, 1.23\u20135.37, <jats:italic>p<\/jats:italic>\u2009=\u20090.012) and most global and domain-specific cognitive scores; and an association of hippocampal-sparing subtype with HA-SVD score (OR 3.30; 95%CI, 1.58\u20136.85, <jats:italic>p<\/jats:italic>\u2009=\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Composite SVD imaging markers reflect overall CAA and\/or HA severity and may have differential associations with cognitive domains and AD subtypes. Our finding supports the possibility that the clinical AD subtypes may reflect differing burdens of underlying CAA and HA microangiopathologies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-022-01083-8","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T08:04:19Z","timestamp":1664525059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Imaging markers of cerebral amyloid angiopathy and hypertensive arteriopathy differentiate Alzheimer disease subtypes synergistically"],"prefix":"10.1186","volume":"14","author":[{"given":"Ting-Bin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiang-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Fu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"issue":"10","key":"1083_CR1","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1212\/WNL.0000000000009058","volume":"94","author":"D Ferreira","year":"2020","unstructured":"Ferreira D, Nordberg A, Westman E. Biological subtypes of Alzheimer disease: a systematic review and meta-analysis. Neurology. 2020;94(10):436\u201348.","journal-title":"Neurology"},{"issue":"3","key":"1083_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"J Graff-Radford","year":"2021","unstructured":"Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, et al. New insights into atypical Alzheimer\u2019s disease in the era of biomarkers. Lancet Neurol. 2021;20(3):222\u201334.","journal-title":"Lancet Neurol"},{"issue":"9","key":"1083_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","volume":"10","author":"ME Murray","year":"2011","unstructured":"Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 2011;10(9):785\u201396.","journal-title":"Lancet Neurol"},{"issue":"10","key":"1083_CR4","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S1474-4422(12)70200-4","volume":"11","author":"JL Whitwell","year":"2012","unstructured":"Whitwell JL, Dickson DW, Murray ME, Weigand SD, Tosakulwong N, Senjem ML, et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer\u2019s disease: a case-control study. Lancet Neurol. 2012;11(10):868\u201377.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1083_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000508625","volume":"49","author":"KA Jellinger","year":"2020","unstructured":"Jellinger KA. Pathobiological subtypes of Alzheimer disease. Dement Geriatr Cogn Disord. 2020;49(4):321\u201333.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"1083_CR6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3233\/JAD-201274","volume":"80","author":"B Zhang","year":"2021","unstructured":"Zhang B, Lin L, Wu S. A Review of brain atrophy subtypes definition and analysis for Alzheimer\u2019s disease heterogeneity studies. J Alzheimers Dis. 2021;80(4):1339\u201352.","journal-title":"J Alzheimers Dis"},{"issue":"Pt 3","key":"1083_CR7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/brain\/aws327","volume":"136","author":"M Lehmann","year":"2013","unstructured":"Lehmann M, Ghosh PM, Madison C, Laforce R Jr, Corbetta-Rastelli C, Weiner MW, et al. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer\u2019s disease. Brain. 2013;136(Pt 3):844\u201358.","journal-title":"Brain"},{"key":"1083_CR8","doi-asserted-by":"publisher","first-page":"46263","DOI":"10.1038\/srep46263","volume":"7","author":"D Ferreira","year":"2017","unstructured":"Ferreira D, Verhagen C, Hern\u00e1ndez-Cabrera JA, Cavallin L, Guo CJ, Ekman U, et al. Distinct subtypes of Alzheimer\u2019s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications. Sci Rep. 2017;7:46263.","journal-title":"Sci Rep"},{"issue":"3","key":"1083_CR9","first-page":"735","volume":"140","author":"A Dong","year":"2017","unstructured":"Dong A, Toledo JB, Honnorat N, Doshi J, Varol E, Sotiras A, et al. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer\u2019s disease: links to cognition, progression and biomarkers. Brain. 2017;140(3):735\u201347.","journal-title":"Brain"},{"issue":"1","key":"1083_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.25123","volume":"83","author":"PA Boyle","year":"2018","unstructured":"Boyle PA, Yu L, Wilson RS, Leurgans SE, Schneider JA, Bennett DA. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018;83(1):74\u201383.","journal-title":"Ann Neurol"},{"issue":"1","key":"1083_CR11","doi-asserted-by":"publisher","first-page":"14579","DOI":"10.1038\/s41598-020-71305-2","volume":"10","author":"DX Thomas","year":"2020","unstructured":"Thomas DX, Bajaj S, McRae-McKee K, Hadjichrysanthou C, Anderson RM, Collinge J. Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer\u2019s disease neuropathology. Sci Rep. 2020;10(1):14579.","journal-title":"Sci Rep"},{"issue":"14","key":"1083_CR12","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1212\/WNL.0b013e31824e8e7f","volume":"78","author":"V Deramecourt","year":"2012","unstructured":"Deramecourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, et al. Staging and natural history of cerebrovascular pathology in dementia. Neurology. 2012;78(14):1043\u201350.","journal-title":"Neurology"},{"issue":"Pt 9","key":"1083_CR13","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/brain\/awt188","volume":"136","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M, et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre. Brain. 2013;136(Pt 9):2697\u2013706.","journal-title":"Brain"},{"issue":"9","key":"1083_CR14","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2011;42(9):2672\u2013713.","journal-title":"Stroke"},{"key":"1083_CR15","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3389\/fneur.2020.00927","volume":"11","author":"HW Kim","year":"2020","unstructured":"Kim HW, Hong J, Jeon JC. Cerebral small vessel disease and Alzheimer\u2019s disease: a review. Front Neurol. 2020;11:927.","journal-title":"Front Neurol"},{"issue":"1","key":"1083_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/bpa.12769","volume":"30","author":"Y Hase","year":"2020","unstructured":"Hase Y, Polvikoski TM, Firbank MJ, Craggs LJL, Hawthorne E, Platten C, et al. Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunction. Brain Pathol. 2020;30(1):191\u2013202.","journal-title":"Brain Pathol"},{"issue":"6","key":"1083_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1212\/WNL.0000000000002362","volume":"86","author":"A Charidimou","year":"2016","unstructured":"Charidimou A, Boulouis G, Haley K, Auriel E, van Etten ES, Fotiadis P, et al. White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology. 2016;86(6):505\u201311.","journal-title":"Neurology"},{"key":"1083_CR18","doi-asserted-by":"crossref","unstructured":"Mahammedi A, Wang LL, Williamson BJ, Khatri P, Kissela B, Sawyer RP, et al. Small vessel disease, a marker of brain health: what the radiologist needs to know. AJNR Am J Neuroradiol. 2021.","DOI":"10.3174\/ajnr.A7302"},{"issue":"3","key":"1083_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/nan.12576","volume":"46","author":"S Schreiber","year":"2020","unstructured":"Schreiber S, Wilisch-Neumann A, Schreiber F, Assmann A, Scheumann V, Perosa V, et al. Invited Review: The spectrum of age-related small vessel diseases: potential overlap and interactions of amyloid and nonamyloid vasculopathies. Neuropathol Appl Neurobiol. 2020;46(3):219\u201339.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1083_CR20","doi-asserted-by":"publisher","first-page":"175628641984411","DOI":"10.1177\/1756286419844113","volume":"12","author":"SJ Chen","year":"2019","unstructured":"Chen SJ, Tsai HH, Tsai LK, Tang SC, Lee BC, Liu HM, et al. Advances in cerebral amyloid angiopathy imaging. Ther Adv Neurol Disord. 2019;12:1756286419844113.","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"1083_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2011.7.1.1","volume":"7","author":"A Biffi","year":"2011","unstructured":"Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol. 2011;7(1):1\u20139.","journal-title":"J Clin Neurol"},{"issue":"8","key":"1083_CR22","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamaneurol.2016.0832","volume":"73","author":"A Charidimou","year":"2016","unstructured":"Charidimou A, Martinez-Ramirez S, Reijmer YD, Oliveira-Filho J, Lauer A, Roongpiboonsopit D, et al. Total magnetic resonance imaging burden of small vessel disease in cerebral amyloid angiopathy: an imaging-pathologic study of concept validation. JAMA Neurol. 2016;73(8):994\u20131001.","journal-title":"JAMA Neurol"},{"issue":"2","key":"1083_CR23","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1212\/WNL.0000000000011050","volume":"96","author":"M Pasi","year":"2021","unstructured":"Pasi M, Sugita L, Xiong L, Charidimou A, Boulouis G, Pongpitakmetha T, et al. Association of cerebral small vessel disease and cognitive decline after intracerebral hemorrhage. Neurology. 2021;96(2):e182\u201392.","journal-title":"Neurology"},{"key":"1083_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.747536","volume":"12","author":"CY Lin","year":"2021","unstructured":"Lin CY, Jhan SR, Lee WJ, Chen PL, Chen JP, Chen HC, et al. Imaging markers of subcortical vascular dementia in patients with multiple-lobar cerebral microbleeds. Front Neurol. 2021;12: 747536.","journal-title":"Front Neurol"},{"key":"1083_CR25","doi-asserted-by":"publisher","first-page":"41637","DOI":"10.1038\/srep41637","volume":"7","author":"D Pinter","year":"2017","unstructured":"Pinter D, Ritchie SJ, Doubal F, Gattringer T, Morris Z, Bastin ME, et al. Impact of small vessel disease in the brain on gait and balance. Sci Rep. 2017;7:41637.","journal-title":"Sci Rep"},{"issue":"1","key":"1083_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13195-020-00620-7","volume":"12","author":"A Machado","year":"2020","unstructured":"Machado A, Ferreira D, Grothe MJ, Eyjolfsdottir H, Almqvist PM, Cavallin L, et al. The cholinergic system in subtypes of Alzheimer\u2019s disease: an in vivo longitudinal MRI study. Alzheimers Res Ther. 2020;12(1):51.","journal-title":"Alzheimers Res Ther"},{"key":"1083_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neurobiolaging.2018.05.028","volume":"70","author":"D Ferreira","year":"2018","unstructured":"Ferreira D, Shams S, Cavallin L, Viitanen M, Martola J, Granberg T, et al. The contribution of small vessel disease to subtypes of Alzheimer\u2019s disease: a study on cerebrospinal fluid and imaging biomarkers. Neurobiol Aging. 2018;70:18\u201329.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"1083_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186595","volume":"12","author":"K Persson","year":"2017","unstructured":"Persson K, Eldholm RS, Barca ML, Cavallin L, Ferreira D, Knapskog AB, et al. MRI-assessed atrophy subtypes in Alzheimer\u2019s disease and the cognitive reserve hypothesis. PLoS ONE. 2017;12(10): e0186595.","journal-title":"PLoS ONE"},{"issue":"24","key":"1083_CR29","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1212\/WNL.0000000000004042","volume":"88","author":"KK Lau","year":"2017","unstructured":"Lau KK, Li L, Schulz U, Simoni M, Chan KH, Ho SL, et al. Total small vessel disease score and risk of recurrent stroke: Validation in 2 large cohorts. Neurology. 2017;88(24):2260\u20137.","journal-title":"Neurology"},{"issue":"14","key":"1083_CR30","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1212\/WNL.0000000000000837","volume":"83","author":"J Staals","year":"2014","unstructured":"Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83(14):1228\u201334.","journal-title":"Neurology"},{"issue":"3","key":"1083_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"1083_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6","volume":"49","author":"E Vakil","year":"1993","unstructured":"Vakil E, Blachstein H. Rey Auditory-Verbal Learning Test: structure analysis. J Clin Psychol. 1993;49(6):883\u201390.","journal-title":"J Clin Psychol"},{"issue":"14","key":"1083_CR33","doi-asserted-by":"publisher","first-page":"7616","DOI":"10.3390\/ijerph18147616","volume":"18","author":"EC Chiu","year":"2021","unstructured":"Chiu EC, Chien TH, Lee YC. Measurement equivalence between the original and estimated mini-mental state examination in people with dementia. Int J Environ Res Public Health. 2021;18(14):7616.","journal-title":"Int J Environ Res Public Health"},{"key":"1083_CR34","doi-asserted-by":"crossref","unstructured":"Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr. 1994;6(1):45\u201358; discussion 62.","DOI":"10.1017\/S1041610294001602"},{"issue":"4","key":"1083_CR35","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1017\/S1041610211002298","volume":"24","author":"CF Tsai","year":"2012","unstructured":"Tsai CF, Lee WJ, Wang SJ, Shia BC, Nasreddine Z, Fuh JL. Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysis. Int Psychogeriatr. 2012;24(4):651\u20138.","journal-title":"Int Psychogeriatr"},{"key":"1083_CR36","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566\u201372.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"1083_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/joim.12358","volume":"278","author":"D Ferreira","year":"2015","unstructured":"Ferreira D, Cavallin L, Larsson EM, Muehlboeck JS, Mecocci P, Vellas B, et al. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer\u2019s disease and mild cognitive impairment. J Intern Med. 2015;278(3):277\u201390.","journal-title":"J Intern Med"},{"issue":"10","key":"1083_CR38","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","volume":"55","author":"P Scheltens","year":"1992","unstructured":"Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"1083_CR39","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1007\/s00330-011-2205-4","volume":"21","author":"EL Koedam","year":"2011","unstructured":"Koedam EL, Lehmann M, van der Flier WM, Scheltens P, Pijnenburg YA, Fox N, et al. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol. 2011;21(12):2618\u201325.","journal-title":"Eur Radiol"},{"issue":"8","key":"1083_CR40","first-page":"2597","volume":"26","author":"D Ferreira","year":"2016","unstructured":"Ferreira D, Cavallin L, Granberg T, Lindberg O, Aguilar C, Mecocci P, et al. Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4. CSF biomarkers and cognition Eur Radiol. 2016;26(8):2597\u2013610.","journal-title":"CSF biomarkers and cognition Eur Radiol"},{"issue":"8","key":"1083_CR41","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822\u201338.","journal-title":"Lancet Neurol"},{"issue":"21","key":"1083_CR42","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/WNL.0b013e3181c34a7d","volume":"73","author":"SM Gregoire","year":"2009","unstructured":"Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, J\u00e4ger HR, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73(21):1759\u201366.","journal-title":"Neurology"},{"issue":"6","key":"1083_CR43","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","volume":"32","author":"LO Wahlund","year":"2001","unstructured":"Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sj\u00f6gren M, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32(6):1318\u201322.","journal-title":"Stroke"},{"issue":"3","key":"1083_CR44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1552-6569.2003.tb00187.x","volume":"13","author":"YH Fan","year":"2003","unstructured":"Fan YH, Lam WW, Mok VC, Huang RX, Wong KS. Variability and validity of a simple visual rating scale in grading white matter changes on magnetic resonance imaging. J Neuroimaging. 2003;13(3):255\u20138.","journal-title":"J Neuroimaging"},{"issue":"2","key":"1083_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351\u20136.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"1083_CR46","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/STROKEAHA.109.564914","volume":"41","author":"FN Doubal","year":"2010","unstructured":"Doubal FN, MacLullich AM, Ferguson KJ, Dennis MS, Wardlaw JM. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41(3):450\u20134.","journal-title":"Stroke"},{"issue":"3","key":"1083_CR47","first-page":"753","volume":"14","author":"GD Jackson","year":"1993","unstructured":"Jackson GD, Berkovic SF, Duncan JS, Connelly A. Optimizing the diagnosis of hippocampal sclerosis using MR imaging. AJNR Am J Neuroradiol. 1993;14(3):753\u201362.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"1083_CR48","first-page":"15","volume":"19","author":"R Bronen","year":"1998","unstructured":"Bronen R. MR of mesial temporal sclerosis: how much is enough? AJNR Am J Neuroradiol. 1998;19(1):15\u20138.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1083_CR49","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fneur.2019.00524","volume":"10","author":"D Ferreira","year":"2019","unstructured":"Ferreira D, Pereira JB, Volpe G, Westman E. Subtypes of Alzheimer\u2019s disease display distinct network abnormalities extending beyond their pattern of brain atrophy. Front Neurol. 2019;10:524.","journal-title":"Front Neurol"},{"issue":"17","key":"1083_CR50","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad605","volume":"74","author":"J Linn","year":"2010","unstructured":"Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology. 2010;74(17):1346\u201350.","journal-title":"Neurology"},{"issue":"11","key":"1083_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142756","volume":"10","author":"MS Byun","year":"2015","unstructured":"Byun MS, Kim SE, Park J, Yi D, Choe YM, Sohn BK, et al. Heterogeneity of regional brain atrophy patterns associated with distinct progression rates in Alzheimer\u2019s disease. PLoS ONE. 2015;10(11): e0142756.","journal-title":"PLoS ONE"},{"key":"1083_CR52","doi-asserted-by":"crossref","unstructured":"J\u00e4kel L, De Kort AM, Klijn CJM, Schreuder F, Verbeek MM. Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis. Alzheimers Dement. 2021.","DOI":"10.1002\/alz.052158"},{"issue":"11","key":"1083_CR53","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.ajpath.2021.07.004","volume":"191","author":"RN Kalaria","year":"2021","unstructured":"Kalaria RN, Sepulveda-Falla D. Cerebral small vessel disease in sporadic and familial alzheimer disease. Am J Pathol. 2021;191(11):1888\u2013905.","journal-title":"Am J Pathol"},{"issue":"9","key":"1083_CR54","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.3390\/ijms22094958","volume":"22","author":"F Paolini Paoletti","year":"2021","unstructured":"Paolini Paoletti F, Simoni S, Parnetti L, Gaetani L. The contribution of small vessel disease to neurodegeneration: focus on Alzheimer\u2019s disease, Parkinson\u2019s disease and multiple sclerosis. Int J Mol Sci. 2021;22(9):4958.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1083_CR55","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00401-020-02215-w","volume":"140","author":"N Korte","year":"2020","unstructured":"Korte N, Nortley R, Attwell D. Cerebral blood flow decrease as an early pathological mechanism in Alzheimer\u2019s disease. Acta Neuropathol. 2020;140(6):793\u2013810.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"1083_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195838","volume":"13","author":"S Lee","year":"2018","unstructured":"Lee S, Zimmerman ME, Narkhede A, Nasrabady SE, Tosto G, Meier IB, et al. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer\u2019s disease. PLoS ONE. 2018;13(5): e0195838.","journal-title":"PLoS ONE"},{"issue":"6","key":"1083_CR57","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24647","volume":"79","author":"S Lee","year":"2016","unstructured":"Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, et al. White matter hyperintensities are a core feature of Alzheimer\u2019s disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol. 2016;79(6):929\u201339.","journal-title":"Ann Neurol"},{"issue":"10","key":"1083_CR58","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.25166","volume":"4","author":"B Rizvi","year":"2021","unstructured":"Rizvi B, Lao PJ, Chesebro AG, Dworkin JD, Amarante E, Beato JM, et al. Association of regional white matter hyperintensities with longitudinal Alzheimer-like pattern of neurodegeneration in older adults. JAMA Netw Open. 2021;4(10): e2125166.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1083_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"ND Prins","year":"2015","unstructured":"Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Rev Neurol. 2015;11(3):157\u201365.","journal-title":"Nat Rev Neurol"},{"key":"1083_CR60","doi-asserted-by":"crossref","unstructured":"Ding R, Hase Y, Ameen-Ali KE, Ndung\u2019u M, Stevenson W, Barsby J, et al. Loss of capillary pericytes and the blood-brain barrier in white matter in poststroke and vascular dementias and Alzheimer\u2019s disease. Brain Pathol. 2020;30(6):1087\u2013101.","DOI":"10.1111\/bpa.12888"},{"key":"1083_CR61","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40478-015-0240-0","volume":"3","author":"KE McAleese","year":"2015","unstructured":"McAleese KE, Firbank M, Dey M, Colloby SJ, Walker L, Johnson M, et al. Cortical tau load is associated with white matter hyperintensities. Acta Neuropathol Commun. 2015;3:60.","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"1083_CR62","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00401-005-1064-y","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J, Jellinger KA, Lintner F. Alzheimer\u2019s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol. 2005;110(3):222\u201331.","journal-title":"Acta Neuropathol"},{"issue":"1\u20132","key":"1083_CR63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jns.2007.01.013","volume":"257","author":"J Attems","year":"2007","unstructured":"Attems J, Quass M, Jellinger KA, Lintner F. Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology. J Neurol Sci. 2007;257(1\u20132):49\u201355.","journal-title":"J Neurol Sci"},{"issue":"21","key":"1083_CR64","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1212\/WNL.0000000000004670","volume":"89","author":"SL Risacher","year":"2017","unstructured":"Risacher SL, Anderson WH, Charil A, Castelluccio PF, Shcherbinin S, Saykin AJ, et al. Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline. Neurology. 2017;89(21):2176\u201386.","journal-title":"Neurology"},{"issue":"3","key":"1083_CR65","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1212\/WNL.0b013e31827deb85","volume":"80","author":"JD Edwards","year":"2013","unstructured":"Edwards JD, Jacova C, Sepehry AA, Pratt B, Benavente OR. A quantitative systematic review of domain-specific cognitive impairment in lacunar stroke. Neurology. 2013;80(3):315\u201322.","journal-title":"Neurology"},{"issue":"2","key":"1083_CR66","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3233\/JAD-170573","volume":"63","author":"E van den Berg","year":"2018","unstructured":"van den Berg E, Geerlings MI, Biessels GJ, Nederkoorn PJ, Kloppenborg RP. White matter hyperintensities and cognition in mild cognitive impairment and Alzheimer\u2019s disease: a domain-specific meta-analysis. J Alzheimers Dis. 2018;63(2):515\u201327.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"1083_CR67","doi-asserted-by":"publisher","first-page":"e1501","DOI":"10.1212\/WNL.0000000000011537","volume":"96","author":"M Paradise","year":"2021","unstructured":"Paradise M, Crawford JD, Lam BCP, Wen W, Kochan NA, Makkar S, et al. Association of dilated perivascular spaces with cognitive decline and incident dementia. Neurology. 2021;96(11):e1501\u201311.","journal-title":"Neurology"},{"issue":"4","key":"1083_CR68","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"1083_CR69","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","volume":"17","author":"H Hampel","year":"2021","unstructured":"Hampel H, Cummings J, Blennow K, Gao P, Jack CR Jr, Vergallo A. Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat Rev Neurol. 2021;17(9):580\u20139.","journal-title":"Nat Rev Neurol"},{"issue":"Suppl 1","key":"1083_CR70","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s40120-017-0069-5","volume":"6","author":"MN Sabbagh","year":"2017","unstructured":"Sabbagh MN, Lue LF, Fayard D, Shi J. Increasing precision of clinical diagnosis of Alzheimer\u2019s disease using a combined algorithm incorporating clinical and novel biomarker data. Neurol Ther. 2017;6(Suppl 1):83\u201395.","journal-title":"Neurol Ther"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01083-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01083-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01083-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T10:08:09Z","timestamp":1664532489000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01083-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1083"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01083-8","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"7 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data collection protocol was approved by the institutional review board and the ethics committee of Taichung Veterans General Hospital (CE21064B). Informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}